DK3074384T3 - Amidderivater til gpr119-agonist - Google Patents

Amidderivater til gpr119-agonist Download PDF

Info

Publication number
DK3074384T3
DK3074384T3 DK14866648.0T DK14866648T DK3074384T3 DK 3074384 T3 DK3074384 T3 DK 3074384T3 DK 14866648 T DK14866648 T DK 14866648T DK 3074384 T3 DK3074384 T3 DK 3074384T3
Authority
DK
Denmark
Prior art keywords
amidderivates
gpr119 agonist
gpr119
agonist
Prior art date
Application number
DK14866648.0T
Other languages
English (en)
Inventor
Yun Tae Kim
Changsik Lee
Daekyu Choi
Moosung Ko
Younghue Han
Soyoung Kim
Jaeki Min
Dohoon Kim
Original Assignee
Chong Kun Dang Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Pharmaceutical Corp filed Critical Chong Kun Dang Pharmaceutical Corp
Application granted granted Critical
Publication of DK3074384T3 publication Critical patent/DK3074384T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK14866648.0T 2013-11-26 2014-11-25 Amidderivater til gpr119-agonist DK3074384T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130144601 2013-11-26
PCT/KR2014/011356 WO2015080446A1 (en) 2013-11-26 2014-11-25 Amide derivatives for gpr119 agonist

Publications (1)

Publication Number Publication Date
DK3074384T3 true DK3074384T3 (da) 2019-07-15

Family

ID=53199342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14866648.0T DK3074384T3 (da) 2013-11-26 2014-11-25 Amidderivater til gpr119-agonist

Country Status (20)

Country Link
US (1) US9776987B2 (da)
EP (1) EP3074384B1 (da)
JP (1) JP6182269B2 (da)
KR (1) KR101700906B1 (da)
CN (2) CN110028494A (da)
AU (1) AU2014354488B2 (da)
BR (1) BR112016011999A2 (da)
CA (1) CA2930850C (da)
DK (1) DK3074384T3 (da)
ES (1) ES2731823T3 (da)
HR (1) HRP20191246T1 (da)
HU (1) HUE045926T2 (da)
MX (1) MX366297B (da)
NZ (1) NZ720304A (da)
PH (1) PH12016500980A1 (da)
PL (1) PL3074384T3 (da)
PT (1) PT3074384T (da)
RU (1) RU2642429C2 (da)
TR (1) TR201908098T4 (da)
WO (1) WO2015080446A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
ES2204409T5 (es) 2000-06-26 2008-04-16 Saudi Basic Industries Corporation Dimerizacion de isobuteno.
DE60132456T2 (de) 2000-07-13 2009-01-08 Merck Patent Gmbh Chirale verbindungen i
ATE269856T1 (de) 2000-10-20 2004-07-15 Merck Patent Gmbh Chirale binaphtol-verbindungen
DE102004037515A1 (de) 2003-08-22 2005-03-17 Merck Patent Gmbh Verfahren zur Herstellung von Aldehyden
WO2008025799A1 (en) * 2006-08-30 2008-03-06 Biovitrum Ab (Publ) Pyridazine compounds for treating gpr119 related disorders
JP5330260B2 (ja) 2006-12-06 2013-10-30 スミスクライン ビーチャム コーポレーション 二環式化合物ならびに抗糖尿病薬としての使用
US20100048632A1 (en) 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine GPCR Agonists
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
BRPI0817211A2 (pt) 2007-09-20 2017-05-16 Irm Llc composto composições como moduladores da atividade de gpr119
WO2009106561A1 (en) * 2008-02-27 2009-09-03 Biovitrum Ab (Publ) Pyrazine compounds for treating gpr119 related disorders
WO2009106565A1 (en) 2008-02-27 2009-09-03 Biovitrum Ab (Publ) Agonists of gpr119
ES2429129T3 (es) 2008-07-11 2013-11-13 Irm Llc 4-Fenoximetilpiperidinas como moduladores de la actividad de GPR119
WO2010048149A2 (en) 2008-10-20 2010-04-29 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
AR077638A1 (es) 2009-07-15 2011-09-14 Lilly Co Eli Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
CA2795513A1 (en) * 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2011145718A1 (ja) 2010-05-21 2011-11-24 田辺三菱製薬株式会社 新規ピロロ[2,3-d]ピリミジン化合物
TW201202230A (en) 2010-05-24 2012-01-16 Mitsubishi Tanabe Pharma Corp Novel quinazoline compound
CN102432598A (zh) 2010-09-29 2012-05-02 江苏恒瑞医药股份有限公司 三环化合物、其制备方法及其在医药上的应用
WO2012069917A1 (en) 2010-11-26 2012-05-31 Lupin Limited Bicyclic gpr119 modulators
WO2012077655A1 (ja) * 2010-12-07 2012-06-14 塩野義製薬株式会社 Gpr119アゴニスト活性を有するスピロ誘導体
JP2014159376A (ja) 2011-06-17 2014-09-04 Taisho Pharmaceutical Co Ltd アザスピロアルカン化合物
DK2858986T3 (da) 2012-06-12 2019-11-25 Chong Kun Dang Pharmaceutical Corp Piperidinderivater som gpr119-agonister
JP5892245B2 (ja) * 2012-06-13 2016-03-23 日産自動車株式会社 車両の駆動力制御装置及び駆動力制御方法

Also Published As

Publication number Publication date
HRP20191246T1 (hr) 2019-12-27
WO2015080446A1 (en) 2015-06-04
CN105873916B (zh) 2019-08-27
NZ720304A (en) 2017-08-25
JP2016538296A (ja) 2016-12-08
JP6182269B2 (ja) 2017-08-16
HUE045926T2 (hu) 2020-01-28
PL3074384T3 (pl) 2019-09-30
CN110028494A (zh) 2019-07-19
KR20150060573A (ko) 2015-06-03
MX366297B (es) 2019-07-04
AU2014354488A1 (en) 2016-06-09
PH12016500980B1 (en) 2016-06-20
PT3074384T (pt) 2019-07-10
BR112016011999A2 (pt) 2017-08-08
CA2930850C (en) 2017-05-16
RU2016125492A (ru) 2018-01-09
US20170129875A1 (en) 2017-05-11
CA2930850A1 (en) 2015-06-04
ES2731823T3 (es) 2019-11-19
PH12016500980A1 (en) 2016-06-20
MX2016006904A (es) 2016-10-28
EP3074384B1 (en) 2019-05-22
EP3074384A4 (en) 2017-04-19
US9776987B2 (en) 2017-10-03
AU2014354488B2 (en) 2017-08-24
CN105873916A (zh) 2016-08-17
RU2642429C2 (ru) 2018-01-25
KR101700906B1 (ko) 2017-01-31
TR201908098T4 (tr) 2019-06-21
EP3074384A1 (en) 2016-10-05

Similar Documents

Publication Publication Date Title
DK3572105T3 (da) Injektionsindretning til terapeutisk middel
LT3057586T (lt) Bromodomeno inhibitoriai
AR095266A1 (es) Inhibidores de bromodominios tetraciclicos
EP2969007A4 (en) HISTONE DEMETHYLASE INHIBITORS
LT3060041T (lt) Prostaciklino junginiai
EP2948458A4 (en) BTK INHIBITORS
DK2970336T3 (da) Tetrahydropyrrolothiazinforbindelser
IL244825B (en) Injection device
EP2948431A4 (en) BTK INHIBITORS
FI20136201A7 (fi) Laitteen tuki
DK2968225T3 (da) Neosaxitoxinkombinationsformuleringer til forlænget lokalanæstesi
DK2956071T3 (da) Sæt til perifer nerveblokering
HUE037417T2 (hu) Szubsztituált imidazopiridazinok
DK3079743T3 (da) Anordning
BR112015022372A2 (pt) dispositivo
DK2999544T3 (da) Substansfragmenterende indretning
IL240904A0 (en) Azetidinyloxyphenylpyrrolidine compounds
DK2837678T3 (da) Fremgangsmåde til forbedret afsmeltning
DK2951552T3 (da) Opfangningsanordning til engangsbrug
DK2882041T3 (da) Lederkontaktpunkt
HRP20180618T1 (hr) Spojevi fluorfenilpirazola
DK2964206T3 (da) Beta-2-adrenerg receptoragonist til forbedring af farvetilpasning af hudar
DE112013007428A5 (de) Komponententräger
DK3074384T3 (da) Amidderivater til gpr119-agonist
DE112013006679T8 (de) Schlaufenziehervorrichtung